Clinical Outcomes of Chronic Lymphocytic Leukemia (CCL) and Mantle Cell Lymphoma (MCL) Participants Treated With Ibrutinib: A Medical Chart Review From India
Clinical trial NCT03476655 · COMPLETED
Trial details
- NCT number
- NCT03476655
- Sponsor
- Johnson & Johnson Private Limited
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-04-28
- Primary completion
- 2019-05-14
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.